The Most Common Types of Lung Cancer

These vary by age, sex, and smoking status

Table of Contents
View All
Table of Contents

It's easy to think that lung cancer is one diagnosis with one possible outcome. The truth is that there are several types of lung cancer with key differences in what causes them. There are also differences in how each type of lung cancer develops in the body and how it is treated.

Most lung cancer diagnoses fall into a few types and subtypes. However, all people with lung cancer have unique experiences, even if they have the same disease.

This article will help you learn more about these types of lung cancer and how they might vary based on age, sex, smoking status, and other factors.

Main Types of Lung Cancer

Primary lung cancers are those that start in the lungs rather than spreading (metastasizing) to the lungs from somewhere else in the body.

There are two main types of primary lung cancers:

A third type, called a carcinoid tumor, is less common in the lungs. It accounts for just 1% to 2% of lung cancers.

NSCLC and SCLC are also broken down into specific subtypes. The names are based on the kinds of cells that make up the tumors when they're seen under a microscope.

Non-Small Cell Lung Cancer

Types of Non-Small Cell Lung Cancer
Verywell / Emily Roberts

NSCLC typically grows and spreads more slowly than SCLC. Both are linked with smoking, but NSCLC is also the most common type of lung cancer in younger people and in people who have never smoked.

The risks and causes may depend on what subtype of NSCLC is diagnosed. There are three main subtypes:

Small Cell Lung Cancer

SCLC is typically an aggressive, fast-growing cancer.

It is strongly linked with smoking, although other factors including radon exposure may be involved. (Radon is an odorless, colorless gas that seeps into homes from the soil around it.)

Two subtypes of SCLC are:

  • Small cell carcinoma
  • Combined small cell carcinoma (cells mixed with another type)


The two main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC, the most common one, has three main subtypes.

Differences Based on Sex

Men continue to have higher incidence rates of lung cancer than women; however, the gap is closing largely due to health policy changes and smoking cessation.

NSCLC is a common lung cancer diagnosis in both men and women, with the adenocarcinoma subtype being the most prevalent. However, researchers describe lung adenocarcinomas as "a different disease in women and men."

Among women, lung adenocarcinomas account for 40% to 60% of their lung cancer cases. Roughly half of these cancers in women are related to smoking, compared to 85% of the cases in men who are smokers. Women also tend to be younger at diagnosis and respond differently to treatments.

Men with NSCLC are more likely to develop squamous cell lung cancer, which is linked with smoking. However, they are less likely to be diagnosed with SCLC than women.

Differences Based on Age

Lung cancer, as with many diseases, is generally more common in older people, with the average age of diagnosis being 70. Only 5% of all cancers are diagnosed in young adults ages 18-39.

Lung adenocarcinoma is the most common type of lung cancer in young adults, accounting for nearly 50% of cases. Carcinoid lung tumors tend to be found most frequently in people aged 45-55, but can be diagnosed at any age, including in children and adolescents. On the other hand, SCLC is relatively rare in young people, seen in less than 5% of lung cancer cases.

Young adults with lung cancer are much more likely to have a genetic factor that contributes to their lung cancer. For this reason, they may have genetic changes that may be treated with newer therapies that target specific mutations.

Smokers vs. Non-Smokers

In many ways, lung cancer in non-smokers is quite different from lung cancer in people who smoke. This applies to even the most common types of the disease.

Both NSCLC and SCLC are linked with a history of smoking, though SCLC's association is much stronger.

Of the three NSCLC subtypes, lung adenocarcinoma is the one most likely to be found in people who never smoked (50% to 60%). Around 10% to 20% of people who never smoked are diagnosed with squamous cell carcinoma. Only 6% to 8% of people who never smoked are diagnosed with SCLC.

Carcinoid tumors do not appear to be associated with smoking. They are found in smokers and non-smokers in numbers that are similar to those seen in the general population.


Current and former smokers develop SCLC and the squamous cell subtype of NSCLC more often than other people. The lung adenocarcinoma subtype of NSCLC is seen more often in women, younger people, and those who have never smoked.

Rates and the Role of Genetics

Lung cancer rates have shifted over time. That's partly because people began to quit or avoid smoking because of the health impacts.

One of the biggest questions, though, is why lung cancer rates have climbed in younger people and those who have never smoked.

Environmental factors like air pollution may be part of the reason, but that doesn't explain many of the cases. Research led by the National Cancer Institute and National Institutes of Health points to genetics.

Their September 2021 study looked at changes in the genes of 232 people with NSCLC diagnoses who never smoked, comparing their normal tissue with tumor samples.

Of the study group, 189 had lung adenocarcinomas while the rest were other types. The study found that gene mutations from natural processes inside the body were associated with the lung cancers.

The researchers also reported three new genetic subtypes of lung cancer in these never-smokers.

While they caution that more research is needed, the findings point to the possibility of future treatment targets.

Targetable Mutations in Lung Cancer

Science continues to delve deeper into the genetic links to lung and other cancers. Still, many healthcare providers and cancer specialists (oncologists) recommend genetic testing for people with cancer.

That's especially true for people with NSCLC lung cancer. Targeted therapies are available or in development for people with specific cancer-related changes (mutations) in genes, including:

Tumors that have treatable mutations are more commonly found in young adults, never-smokers, and women. However, many other people with lung cancer may benefit from targeted therapies as well.


Smoking is a main, but not the only, cause of lung cancer. Genetics may play a key role, especially in younger people, women, and never-smokers. Genetic testing may be recommended to see if you have a mutation for which there is an available treatment.


There are several types and subtypes of lung cancer, most of which are forms of either non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC). There are differences among these types.

One of the most important may be that smoking remains a top reason for some lung cancers, and is associated with both NSCLC and SCLC types, but many other lung cancers are diagnosed in people who have never smoked.

Radon and other environmental causes may contribute to these cancers. In some cases, particularly among younger people, there may be an underlying genetic reason.

A Word From Verywell

NSCLC tends to grow more slowly than small cell lung cancer and have a better prognosis. That said, long-term survival from any form of lung cancer is higher when found in the earlier stages of the disease.

Lung cancer screening is recommended for people ages 50 to 80 with at least a 20 pack-year history of smoking, and who smoked or quit smoking in the past 15 years.

If you've never smoked, you may still want to ask about screening. A 2019 study in the Journal of Thoracic Oncology found that low-dose computerized tomography (CT) imaging helped find early-stage cancers that would have otherwise been missed in both smokers and never-smokers.

24 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. American Cancer Society. Key statistics for lung cancer.

  2. American Cancer Society. Key statistics for lung carcinoid tumor.

  3. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: Epidemiology, etiology, and preventionClinics in Chest Medicine. 2011;32(4):605-644. doi:10.1016/j.ccm.2011.09.001

  4. Perez-Moreno P, Brambilla E, Thomas R, Soria JC. Squamous cell carcinoma of the lung: Molecular subtypes and therapeutic opportunities. Clinical Cancer Research. 2012;18(9):2443-2451. doi:10.1158/1078-0432.CCR-11-2370

  5. National Organization of Rare Diseases. Small cell lung cancer.

  6. United States Environmental Protection Agency. Health risks of radon.

  7. National Cancer Institute. Small cell lung cancer treatment (PDQ®)–patient version.

  8. American Lung Association. Lung cancer prevalence and incidence.

  9. North CM, Christiani DC. Women and lung cancer: What is new?Semin Thorac Cardiovasc Surg. 2013;25(2):87-94. doi:10.1053%2Fj.semtcvs.2013.05.002

  10. Rodriguez-Lara V, Avila-Costa MR. An overview of lung cancer in women and the impact of estrogen in lung carcinogenesis and lung cancer treatmentFront Med. 2021;8:600121. doi:10.3389/fmed.2021.600121

  11. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countriesEur J Cancer 2004;40:96-125. doi:10.1016/j.ejca.2003.08.005

  12. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case-control studiesInt J Cancer. 2012;131(5):1210-1219. doi:10.1002/ijc.27339

  13. Barrera-Rodriguez R, Morales-Fuentes J. Lung cancer in womenLung Cancer (Auckl). 2012;3:79-89. doi:10.2147/LCTT.S37319

  14. American Cancer Society. Types of cancers that develop in young adults.

  15. Liu B, Quan X, Xu C, et al. Lung cancer in young adults aged 35 years or younger: A full-scale analysis and reviewJ Cancer. 2019;10(15):3553-3559. doi:10.7150%2Fjca.27490

  16. Rich AL, Khakwani A, Free CM, et al. Non-small cell lung cancer in young adults: Presentation and survival in the English National Lung Cancer AuditQJM. 2015;108(11):891-897. doi:10.1093/qjmed/hcv052

  17. American Cancer Society. Risk factors for lung carcinoid tumors.

  18. Kozielski J, Kaczmarczyk G, Porębska I, Szmygin-Milanowska K, Gołecki M. Lung cancer in patients under the age of 40 yearsContemporary Oncology. 2012;5:413-415. doi:10.5114%2Fwo.2012.31770

  19. Lee MH, Qureshi MM, Suzuki K, Everett P, Tapan U, Mak KS. Small cell lung cancer in young patients: Trends in sociodemographic factors, diagnosis, treatment, and survivalJournal of Thoracic Disease. 2022;14(8).

  20. Centers for Disease Control and Prevention. Lung cancer among people who never smoked.

  21. Zhang T, Joubert P, Ansari-Pour N, et al. Genomic and evolutionary classification of lung cancer in never smokersNat Genet. 2021;53(9):1348-1359. doi:10.1038/s41588-021-00920-0

  22. American Cancer Society. Targeted drug therapy for non-small cell lung cancer.

  23. United States Preventive Services Taskforce. Lung cancer: Screening.

  24. Kang HR, Cho JY, Lee SH, et al. Role of low-dose computerized tomography in lung cancer screening among never-smokersJournal of Thoracic Oncology. 2019;14(3):436-444. doi:10.1016/j.jtho.2018.11.002

Additional Reading

By Lynne Eldridge, MD
 Lynne Eldrige, MD, is a lung cancer physician, patient advocate, and award-winning author of "Avoiding Cancer One Day at a Time."